$AUMN

Golden Minerals Co

CIK:0001011509|SEC Filings

Condensed Consolidated Statements of Operations - (Unaudited) - USD ($)
$ in Thousands

3 Months Ended

6 Months Ended

Jun. 30, 2026

Jun. 30, 2025

Jun. 30, 2026

Jun. 30, 2025

Costs and expenses:

Exploration expense

$ (27)

$ (81)

$ (86)

$ (152)

Administrative expense

(345)

(748)

(834)

(1,463)

Stock-based compensation

(72)

(99)

(145)

(173)

Other operating income (expense), net

(5)

Total costs and expenses

(444)

(933)

(1,065)

(1,793)

Loss from operations

(444)

(933)

(1,065)

(1,793)

Other income (expense):

Interest and other income (expense), net

Gain (loss) on foreign currency transactions

(8)

(42)

(8)

(42)

Total other income (expense)

(2)

Loss from operations before income taxes and discontinued operations

(446)

(923)

(1,062)

(1,757)

Income taxes (Note 9)

Loss from continuing operations

(446)

(923)

(1,062)

(1,757)

Income (loss) from discontinued operations, net of taxes (Note 3)

1,128

1,142

(319)

Net income (loss)

$ 682

$ (840)

$ 80

$ (2,076)

Net income (loss) per common share - basic

Continuing operations

$ (0.03)

$ (0.06)

$ (0.07)

$ (0.12)

Discontinued operations

0.07

(0.02)

Net income (loss) per common share - basic

$ 0.04

$ (0.06)

$ 0

$ (0.14)

Weighted-average shares outstanding - basic

16,788,213

^[1]

15,053,048

^[1]

15,925,424

15,052,713

[1]

Potentially dilutive shares have not been included for loss periods because to do so would be anti-dilutive. Potentially dilutive shares at June 30, 2026, consist of 2,670,079 equivalent shares related to restricted stock units and 7,427,587 equivalent shares related to outstanding warrants. Potentially dilutive shares at June 30, 2025, consist of 2,470,079 equivalent shares related to stock-based awards and 7,481,587 equivalent shares related to outstanding warrants. See Note 10 for a discussion of stock-based compensation and warrants.

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Cash flows provided by (used in) operating activities:
Net income (loss)	$ 682	$ (840)	$ 80	$ (2,076)
(Income) loss from discontinued operations	(1,128)	(83)	(1,142)	319
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	72	99	145	173
Gain on sale of assets				(600)
Changes in operating assets and liabilities:
Value added tax receivable, net				314
Prepaid expenses and other assets			(70)	148
Right-of-use assets				9
Accounts payable and other accrued liabilities			(436)	(468)
Other current liabilities				(42)
Net cash provided by (used in) operating activities - continuing operations			(1,423)	(2,223)
Net cash provided by operating activities - discontinued operations			(5)	(199)
Net cash provided by (used in) operating activities			(1,428)	(2,422)
Cash flows provided by (used in) investing activities:
Net cash provided by (used in) investing activities - continuing operations
Net cash provided by (used in) investing activities - discontinued operations			1,200	1,748
Net cash provided by (used in) investing activities			1,200	1,748
Cash flows provided by (used in) financing activities:
Net cash provided by (used in) financing activities - continuing operations			848
Net cash provided by (used in) financing activities - discontinued operations
Net cash provided by (used in) financing activities			848
Net increase (decrease) in cash, cash equivalents, and restricted cash			620	(674)
Cash, cash equivalents, and restricted cash, beginning of period			1,834	3,175
Cash, cash equivalents, and restricted cash, end of period	2,454	2,501	2,454	2,501
Reconciliation of cash, cash equivalents, and restricted cash to the balance sheet:
Cash and cash equivalents, end of period	2,454	2,501	2,454	2,501
Restricted cash, end of period
Total cash, cash equivalents, and restricted cash, end of period	$ 2,454	$ 2,501	2,454	2,501
Cash and cash equivalents, beginning of period			1,339	3,175
Restricted cash, beginning of period			495
Total cash, cash equivalents, and restricted cash, beginning of period			1,834	3,175
Supplemental disclosure:
Cash paid for income taxes			3
Cash paid for interest
Insurance premiums financed (non-cash)			$ 152

Condensed Consolidated Balance Sheets - (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 2,454	$ 1,339
Restricted cash		495
Prepaid expenses and other assets (Note 5)	177	107
Total current assets	2,631	1,941
Property, plant and equipment, net (Note 6)	22	22
Investments	265	265
Total assets	2,918	2,228
Current liabilities
Accounts payable and other accrued liabilities (Note 5 & 7)	1,026	1,364
Total current liabilities	1,026	1,364
Total liabilities	1,026	1,364
Commitments and contingencies (Note 11)
Equity (Note 10)
Common stock, $.01 par value, 100,000,000 shares authorized; 18,893,048 and 15,053,048 shares issued and outstanding, respectively	188	150
Additional paid-in capital	553,759	552,849
Accumulated deficit	(552,055)	(552,135)
Shareholders’ equity	1,892	864
Total liabilities and equity	$ 2,918	$ 2,228